Vitalhub (TSE:VHI) Upgraded at Stifel Canada

Stifel Canada upgraded shares of Vitalhub (TSE:VHIFree Report) to a strong-buy rating in a research report released on Tuesday morning,Zacks.com reports.

VHI has been the topic of a number of other research reports. TD Securities raised their target price on Vitalhub from C$15.00 to C$16.00 and gave the company a “buy” rating in a report on Monday, August 11th. Royal Bank Of Canada set a C$15.00 target price on Vitalhub and gave the company a “moderate buy” rating in a report on Thursday, September 18th. Stifel Nicolaus set a C$15.00 target price on Vitalhub and gave the company a “buy” rating in a report on Wednesday. Scotiabank raised their target price on Vitalhub from C$14.00 to C$14.50 and gave the company an “outperform” rating in a report on Friday, June 20th. Finally, National Bankshares set a C$16.00 target price on Vitalhub and gave the company an “outperform” rating in a report on Thursday, August 21st. Two research analysts have rated the stock with a Strong Buy rating and seven have issued a Buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of C$14.86.

View Our Latest Stock Analysis on VHI

Vitalhub Stock Performance

Shares of VHI stock opened at C$10.47 on Tuesday. The stock’s fifty day moving average price is C$11.83 and its two-hundred day moving average price is C$11.34. The company has a market cap of C$657.83 million, a PE ratio of 130.88, a P/E/G ratio of 1.18 and a beta of 0.62. Vitalhub has a fifty-two week low of C$8.50 and a fifty-two week high of C$14.64.

Insider Buying and Selling at Vitalhub

In related news, Director Danny Matlow sold 150,000 shares of the firm’s stock in a transaction on Thursday, August 28th. The stock was sold at an average price of C$12.75, for a total transaction of C$1,912,500.00. Following the sale, the director owned 520,001 shares of the company’s stock, valued at C$6,630,012.75. This trade represents a 22.39% decrease in their position. Also, Director Steve Garrington sold 20,000 shares of the firm’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of C$12.90, for a total value of C$258,000.00. Following the sale, the director directly owned 60,000 shares in the company, valued at approximately C$774,000. This trade represents a 25.00% decrease in their position. Company insiders own 18.57% of the company’s stock.

Vitalhub Company Profile

(Get Free Report)

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.

Featured Stories

Analyst Recommendations for Vitalhub (TSE:VHI)

Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.